Ruhi, C. Et Al. 2015. Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients. EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.13, no.1 , 35-40.

Ruhi, C., SÜLEYMANLAR, İ., KOÇAK, H., Dinckan, A., Ersoy, F., & SÜLEYMANLAR, G., (2015). Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients. EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.13, no.1, 35-40.

Ruhi, Caglar Et Al. "Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients," EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.13, no.1, 35-40, 2015

Ruhi, Caglar Et Al. "Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients." EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.13, no.1, pp.35-40, 2015

Ruhi, C. Et Al. (2015) . "Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients." EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.13, no.1, pp.35-40.

@article{article, author={Caglar Ruhi Et Al. }, title={Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients}, journal={EXPERIMENTAL AND CLINICAL TRANSPLANTATION}, year=2015, pages={35-40} }